Piotr Wojcieszek
Papers
1
Total Citations
7
H-Index
1
About
Piotr Wojcieszek is a clinical researcher whose work centers on advancing radiotherapy techniques for prostate cancer, with a particular focus on robotic ultrahypofractionated stereotactic body radiotherapy (SBRT) using the CyberKnife™ system. His major contribution lies in demonstrating the safety and feasibility of this high-precision, five-fraction treatment approach. In his most cited study, "Acute toxicity of robotic ultrahypofractionated radiotherapy CyberKnife™ in prostate cancer patients" (2015), Wojcieszek prospectively evaluated 132 men with low- and intermediate-risk prostate cancer, reporting a mean age of 69 and a total dose of 36.25 Gy delivered in five fractions. This work, with 7 citations, provided early evidence that such an aggressive regimen yields manageable acute toxicity, helping to validate the clinical adoption of ultrahypofractionation. By systematically documenting patient outcomes, Wojcieszek has contributed to the growing body of evidence supporting shorter, more convenient treatment schedules that maintain efficacy while reducing patient burden. His research continues to inform radiation oncology practice, particularly in the context of robotic radiosurgery, and underscores the importance of prospective trials in refining prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1